Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - Page 3

Short Sellers Hike Their Bets in Major Biotechs

The short interest data are out for the most recent settlement date, October 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Are Investors Giving Alexion Enough Credit for Earnings?

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) reported its most recent quarterly results before the markets opened on Wednesday. The company said that it had $2.02 in earnings per share (EPS) and ...
Read Full Story »

Top Biotech Earnings Reports to Watch This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week. While ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, September 28. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Wednesday’s Biggest Winners and Losers in the S&P 500

September 26, 2018: The S&P 500 closed down 0.3% at 2,906.25. The DJIA closed down 0.4% at 26,389.42. Separately, the Nasdaq closed flat at 7,990.37. Wednesday was a down day ...
Read Full Story »

Major Biotechs Have Short Sellers on the Run

The short interest data are out for the most recent settlement date, September 14. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Up the Ante in Major Biotechs

The short interest data are out for the most recent settlement date, August 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the most recent settlement date, August 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Why Have Short Sellers Backed Off Major Biotechs?

The short interest data are out for the most recent settlement date, July 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotechs See a Rising Tide of Short Interest

The short interest data are out for the most recent settlement date, July 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week

Earnings reporting season for the second quarter is now well underway. So far, things are looking good. The biotech industry has yet to see any significant earnings representation. That will ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, June 29. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the most recent settlement date, June 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Up the Ante For Major Biotechs

The short interest data are out for the most recent settlement date, May 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks ...
Read Full Story »

Short Interest Remains Mixed in Major Biotechs

The short interest data are out for the most recent settlement date, May 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »